Vivo Panda Fund, L.P. is 10% Owner at Bolt Biotherapeutics, Inc. (BOLT). They have made 2 open-market trades across 1 company since 2021, most recently 2021-02-09.
CIK 0001675490
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3.0M since 2021, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BOLT | 1,821,483 | $7.8M |
Shares reported on the most recent Form 4, priced at the 2021-02-09 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.